에 대한 최신 뉴스 Aptose Biosciences (OTC:APTOF) 주식

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

APTOSE BIOSCIENCES INC by Aptose Biosciences. Inc.

Aptose Biosciences Inc

Press Releases

Aptose Provides Clinical Update for the Tuspetinib-based Triple Drug Frontline Therapy in Newly Diagnosed AML Patients from the Phase 1/2 TUSCANY Trial

Comments

Aptose Biosciences

뉴스

에 대한 최신 뉴스 Aptose Biosciences (OTC:APTOF) 주식

뉴스

파트너 / 기고자

벤징가 글로벌